• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human TrKC Polyclonal Antibody

The antibody against TrKC was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 40-300 of human TrKC (NP_001007157.1) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IF/ICC, ELISA.

ADA-03650A

The antibody against TrKC was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 40-300 of human TrKC (NP_001007157.1) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IF/ICC, ELISA.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADA-03650A ClonalityPolyclonal
Host SpeciesRabbitTarget NameTrKC
Target SynonymsTRKC; GP145-TrkC; gp145(trkC); TrKCFormLiquid
Species ReactivityHuman, Mouse, RatIsotypeIgG
Storage Buffer50% Glycerol, PBS with 0.02% sodium azide, pH7.3.Purification MethodAffinity purification
Positive SamplesA-549, BT-474, HepG2, MCF7, Mouse brain, Mouse liverApplicationELISA, WB, IF/ICC

Immunogen Information


Immunogen DescriptionRecombinant fusion protein containing a sequence corresponding to amino acids 40-300 of human TrKC (NP_001007157.1).Target SpeciesHuman
Uniprot IDQ16288Immunogen Sequence
Background Information
  • Uniprot Id

    Q16288

  • Target Species

    Human

  • Target Name

    NTRK3

  • Target Full Name

    NT-3 growth factor receptor

  • Target Function

    Receptor tyrosine kinase involved in nervous system and probably heart development. Upon binding of its ligand NTF3/neurotrophin-3, NTRK3 autophosphorylates and activates different signaling pathways, including the phosphatidylinositol 3-kinase/AKT and the MAPK pathways, that control cell survival and differentiation.

  • Target Involvement

    Defects in NTRK3 are associated with susceptibility to congenital heart defects (CHD). A disease characterized by congenital developmental abnormalities involving structures of the heart. CHD are the most common major birth defects and the leading cause of death from congenital malformations.

  • Target Subcellular Location

    Membrane; Single-pass type I membrane protein.

  • Target Protein Families

    Protein kinase superfamily, Tyr protein kinase family, Insulin receptor subfamily

  • Target Tissue Specificity

    Widely expressed but mainly in nervous tissue. Isoform 2 is expressed at higher levels in adult brain than in fetal brain.

  • Target Synonyms

    EC 2.7.10.1; ETS related protein neurotrophic receptor tyrosine kinase fusion; ETS related protein neurotrophic receptor tyrosine kinase fusion protein; ETV6 NTRK3 fusion ; GP145 TrkC ; gp145(trkC) ; GP145-TrkC; GP145TrkC ; Neurotrophic tyrosine kinase receptor type 3; Neurotrophin 3 receptor ; NT 3 growth factor receptor ; NT 3 growth factor receptor precursor ; NT 3 receptor; NT-3 growth factor receptor; Ntrk3; NTRK3_HUMAN; OTTHUMP00000192915; TRK C; Trk-C; TRKC; TrkC tyrosine kinase; Tyrosine kinase receptor C

  • Target Background

    This gene encodes a member of the neurotrophic tyrosine receptor kinase (NTRK) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. Signalling through this kinase leads to cell differentiation and may play a role in the development of proprioceptive neurons that sense body position. Mutations in this gene have been associated with medulloblastomas, secretory breast carcinomas and other cancers. Several transcript variants encoding different isoforms have been found for this gene.

Inquire Rabbit anti-Human TrKC Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification